ArticleFrontiers in oncology2022

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.

Clara Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.